PharmaBiome Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.36M

  • Investors
  • 6

PharmaBiome General Information

Description

Developer of biology-based analysis tool designed to formulate fecal microbiota transplant products. The company's platform makes microbiota therapy the new standard for the treatment of intestinal diseases and treats intestinal infections without using fecal transplants, enabling patients to recover from intestinal infections such as difficile infection.

Contact Information

Website
www.pharmabiome.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Wagistrasse 27
  • 8952 Schlieren
  • Switzerland
+41 044
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • Wagistrasse 27
  • 8952 Schlieren
  • Switzerland
+41 044

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaBiome Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC (Series A) 10-Sep-2021 $2.36M Completed Pre-Clinical Trials
10. Angel (individual) 08-Jul-2020 Completed Pre-Clinical Trials
9. Accelerator/Incubator 16-Jan-2020 Completed Pre-Clinical Trials
8. Accelerator/Incubator 03-Dec-2019 Completed Startup
7. Angel (individual) 02-May-2019 Completed Startup
6. Grant 31-Jul-2018 Completed Startup
5. Angel (individual) 23-May-2018 Completed Startup
4. Angel (individual) 16-Jun-2017 Completed Startup
3. Angel (individual) 09-Dec-2016 $124K $257K Completed Startup
2. Accelerator/Incubator 14-Jun-2016 $133K $133K Completed Startup
To view PharmaBiome’s complete valuation and funding history, request access »

PharmaBiome Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
Ordinary
Ordinary 120,482 $0.109056 $0.91 $0.91 1x $0.91 5.24%
Ordinary 84,338 $0.109056 $0.33 $0.33 1x $0.33 3.67%
To view PharmaBiome’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

PharmaBiome Patents

  • 31

    Total Documents Applications and Grants

  • Total Patents Families

  • 18

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

PharmaBiome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4453251-A1 New biomarker for disorders and diseases associated with intestinal dysbiosis Pending 22-Dec-2021
US-20230227885-A1 Microbial niche mapping Pending 31-Jul-2020
EP-4188400-A1 Microbial niche mapping Pending 31-Jul-2020
EP-4045668-A1 Use of glycerol for increasing butyrate production by bacteria in a consortium Pending 15-Oct-2019
EP-3866821-A1 Consortia of living bacteria useful for treatment of colorectal cancer Active 15-Oct-2018 A61K35/747
To view PharmaBiome’s complete patent history, request access »

PharmaBiome Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaBiome Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Patrik Forrer Angel (individual)
Thomas Meier Angel (individual)
BASELAUNCH Accelerator/Incubator
EIT Health Accelerator/Incubator
Horizon 2020 SME Instrument Government
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

PharmaBiome FAQs

  • When was PharmaBiome founded?

    PharmaBiome was founded in 2015.

  • Where is PharmaBiome headquartered?

    PharmaBiome is headquartered in Schlieren, Switzerland.

  • What is the size of PharmaBiome?

    PharmaBiome has 10 total employees.

  • What industry is PharmaBiome in?

    PharmaBiome’s primary industry is Discovery Tools (Healthcare).

  • Is PharmaBiome a private or public company?

    PharmaBiome is a Private company.

  • What is the current valuation of PharmaBiome?

    The current valuation of PharmaBiome is .

  • What is PharmaBiome’s current revenue?

    The current revenue for PharmaBiome is .

  • How much funding has PharmaBiome raised over time?

    PharmaBiome has raised $6.94M.

  • Who are PharmaBiome’s investors?

    Patrik Forrer, Thomas Meier, BASELAUNCH, EIT Health, and Horizon 2020 SME Instrument are 5 of 6 investors who have invested in PharmaBiome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »